CCP
Cardan Capital Partners Portfolio holdings
AUM
$893M
1-Year Est. Return
22.82%
1 Year Est. Return
+22.82%
AUM
$899M
AUM Growth
+$66M
(+7.9%)
Holding
288
Top Buys
| 1 | +$34.2M | |
| 2 | +$30.2M | |
| 3 | +$12.8M | |
| 4 |
JPMorgan USD Emerging Markets Sovereign Bond ETF
JPMB
|
+$12.8M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$7.95M |
Top Sells
| 1 | +$38.5M | |
| 2 | +$30M | |
| 3 | +$13.9M | |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$12.5M |
| 5 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$11.2M |
Sector Composition
| 1 | Technology | 13.17% |
| 2 | Consumer Discretionary | 6.08% |
| 3 | Industrials | 3.93% |
| 4 | Communication Services | 3.56% |
| 5 | Financials | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.48B
| – | – |
-80,252
|
|
||
277
State Street SPDR S&P 1500 Momentum Tilt ETF
MMTM
$157M
| – | – |
-22,114
|
|
||
278
Neurocrine Biosciences
NBIX
$15.4B
| – | – |
-29,289
|
|
||
279
Invesco S&P SmallCap Health Care ETF
PSCH
$155M
| – | – |
-40,740
|
|
||
280
Ultragenyx Pharmaceutical
RARE
$3.5B
| – | – |
-38,551
|
|
||
281
Schwab Long-Term US Treasury ETF
SCHQ
$975M
| – | – |
-175,516
|
|
||
282
Invesco S&P 500 Momentum ETF
SPMO
$13B
| – | – |
-66,595
|
|
||
283
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.8B
| – | – |
-160,319
|
|
||
284
Vanguard Real Estate ETF
VNQ
$33.8B
| – | – |
-2,250
|
|
||
|
285
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.63B
| – | – |
-84,846
|
|
||
|
EGIO
286
DELISTED
Edgio, Inc. Common Stock
EGIO
| – | – |
-250
|
|
||
|
RSX
287
DELISTED
VanEck Russia ETF
RSX
| – | – |
-8,169
|
|
||
|
RSXJ
288
DELISTED
VanEck Russia Small-Cap ETF
RSXJ
| – | – |
-5,620
|
|